Atom Investors LP Global Blood Therapeutics, Inc. Transaction History

Atom Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$45.7 - $81.86 $3.56 Million - $6.38 Million	-77,918 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $5.35 Million - $6.83 Million	-117,901 Reduced 60.21%	77,918 $3.78 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $1.04 Million - $1.25 Million	19,724 Added 11.2%	195,819 $10.3 Million
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $497,835 - $665,772	-12,449 Reduced 6.6%	176,095 $9.32 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $5.95 Million - $8.8 Million	188,544 New	188,544 $7.74 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.